Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive ...

According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion ...

HCM and DCM are among the most common inherited heart diseases. Both can cause serious problems like heart failure and sudden ...

A venture firm in Japan says it has applied to the health ministry for approval to produce and sell sheets of heart muscle ...

Hypertrophic cardiomyopathy (HCM) affects 1 in 500 people and is a leading cause of sudden death and heart failure. Although traditionally seen as a genetic disorder, only one-third of cases have ...

Although lifestyle choices can lead to heart disease, there are certain diagnoses that are the product of genetics alone.